HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

0.000p
   
  • Closing Price Chg:
    -5.00p
  • 52 Week High: 290.00p
  • 52 Week Low: 189.00p
  • Currency: UK Pounds
  • Shares Issued: 872.15m
  • Volume: 0
  • RiskGrade: 226
  • Beta: 1.51

Latest ShareCast News

Hutchmed enrols last patient in phase three lung cancer trial

By Josh White

Date: Wednesday 05 Nov 2025

(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment for its global phase three 'Saffron' trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients with MET overexpression or amplification who had progressed following Tagrisso treatment.

HCM ShareCast News

Hutchmed takes wraps off expanding oncology pipe... 03-Nov-2025 ShareCast
Hutchmed upbeat on preclinical data for novel ca... 23-Oct-2025 ShareCast
Hutchmed to present new and updated clinical data 05-Sep-2025 ShareCast
Hutchmed enrols last patient in phase 3 lung can... 20-Aug-2025 ShareCast
Hutchmed to get milestone payment after China dr... 30-Jun-2025 ShareCast

HCM Regulatory News

Vesting of awards under Long Term Incentive Plan 21-Oct-2025 09:30 RNS
Appointment of Independent Non-executive Director 14-Oct-2025 09:30 RNS
Total Voting Rights 30-Sep-2025 09:30 RNS
Directorate Change 26-Aug-2025 07:00 RNS
2025 Interim Results 07-Aug-2025 12:00 RNS

HCM Newspaper Links

Chinese medicine firm employs Cambridge Universi... 23-Dec-2009 Guardian
Joint venture offers food for growth 09-Oct-2009 The Scotsman
Chi-Med unveils maiden profit 31-Jul-2009 The Scotsman
Chi-Med happy with drug tests 14-Jul-2009 The Scotsman
'Watershed' year depends on US drugs trial says ... 17-Mar-2009 The Scotsman

HCM Tips & Analysis

Questor: Hutchison China Meditech 03-Jul-2007 Telegraph
The Week Ahead: Wolseley investors seek calm ami... 19-Mar-2007 The Independent
The Investment Column: Hutchison China MediTech 21-Nov-2006 The Independent
Shares That Sound Good 02-Jun-2006 Motley Fool UK

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 229.00p
Closing Price Change -5.00p
% Change 0.00 %
52 Week High 290.00p
52 Week Low 189.00p
Volume 0
Shares Issued 872.15m
Beta 1.51
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average
31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average
Price Trend
21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Income Not Available
Growth
44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

HCM Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page